A carregar...
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
Low-dose metronomic chemotherapy is a promising therapeutic cancer treatment strategy thought to have an antiangiogenic basis. However, the advantages of reduced toxicity, increased efficacy in some cases, and ability to combine chemotherapy administered long term in this way with targeted therapies...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society of Hematology
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1895327/ https://ncbi.nlm.nih.gov/pubmed/15998832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-04-1422 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|